Roche wins Chinese approval for Actemra to combat coronavirus complications

02:30 EST 5 Mar 2020 | Pharmaceutical Technology

Follow the latest updates of the outbreak on our timeline. Swiss healthcare company Roche has secured approval from China for its anti-inflammation drug...
Read More...

The post Roche wins Chinese approval for Actemra to combat coronavirus complications appeared first on Pharmaceutical Technology.

More From BioPortfolio on "Roche wins Chinese approval for Actemra to combat coronavirus complications"